164 related articles for article (PubMed ID: 21436714)
1. Time to initiation of antiretroviral therapy among patients with HIV-associated tuberculosis in Cape Town, South Africa.
Lawn SD; Campbell L; Kaplan R; Boulle A; Cornell M; Kerschberger B; Morrow C; Little F; Egger M; Wood R;
J Acquir Immune Defic Syndr; 2011 Jun; 57(2):136-40. PubMed ID: 21436714
[TBL] [Abstract][Full Text] [Related]
2. Delays in starting antiretroviral therapy in patients with HIV-associated tuberculosis accessing non-integrated clinical services in a South African township.
Lawn SD; Campbell L; Kaplan R; Little F; Morrow C; Wood R;
BMC Infect Dis; 2011 Sep; 11():258. PubMed ID: 21957868
[TBL] [Abstract][Full Text] [Related]
3. Impact of ART on TB case fatality stratified by CD4 count for HIV-positive TB patients in Cape Town, South Africa (2009-2011).
Kaplan R; Caldwell J; Middelkoop K; Bekker LG; Wood R
J Acquir Immune Defic Syndr; 2014 Aug; 66(5):487-94. PubMed ID: 24820105
[TBL] [Abstract][Full Text] [Related]
4. HIV and TB co-infection in the ART era: CD4 count distributions and TB case fatality in Cape Town.
Kaplan R; Hermans S; Caldwell J; Jennings K; Bekker LG; Wood R
BMC Infect Dis; 2018 Jul; 18(1):356. PubMed ID: 30064368
[TBL] [Abstract][Full Text] [Related]
5. Immune recovery after starting ART in HIV-infected patients presenting and not presenting with tuberculosis in South Africa.
Schomaker M; Egger M; Maskew M; Garone D; Prozesky H; Hoffmann CJ; Boulle A; Fenner L;
J Acquir Immune Defic Syndr; 2013 May; 63(1):142-5. PubMed ID: 23364513
[TBL] [Abstract][Full Text] [Related]
6. Time to initiation of antiretroviral therapy in HIV-infected patients diagnosed with an opportunistic disease: a cohort study.
Deconinck L; Yazdanpanah Y; Gilson RJ; Melliez H; Viget N; Joly V; Sabin CA
HIV Med; 2015 Apr; 16(4):219-29. PubMed ID: 25522796
[TBL] [Abstract][Full Text] [Related]
7. HIV-related symptoms and management in HIV and antiretroviral therapy patients in KwaZulu-Natal, South Africa: a longitudinal study.
Peltzer K
SAHARA J; 2013; 10(2):96-104. PubMed ID: 24405285
[TBL] [Abstract][Full Text] [Related]
8. Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa.
Lawn SD; Myer L; Bekker LG; Wood R
AIDS; 2007 Jan; 21(3):335-41. PubMed ID: 17255740
[TBL] [Abstract][Full Text] [Related]
9. Optimum time to start antiretroviral therapy in patients with HIV-associated tuberculosis: before or after tuberculosis diagnosis?
Kerkhoff AD; Wood R; Lawn SD
AIDS; 2011 Apr; 25(7):1003-6. PubMed ID: 21346513
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of the interval between the initiation of antiretroviral therapy and the initiation of anti-tuberculosis treatment in HIV/tuberculosis-coinfected patients: results from the TREAT Asia HIV Observational Database.
Han SH; Zhou J; Lee MP; Zhao H; Chen YM; Kumarasamy N; Pujari S; Lee C; Omar SF; Ditangco R; Phanuphak N; Kiertiburanakul S; Chaiwarith R; Merati TP; Yunihastuti E; Tanuma J; Saphonn V; Sohn AH; Choi JY;
HIV Med; 2014 Feb; 15(2):77-85. PubMed ID: 23980589
[TBL] [Abstract][Full Text] [Related]
11. Integration of antiretroviral therapy with tuberculosis treatment.
Abdool Karim SS; Naidoo K; Grobler A; Padayatchi N; Baxter C; Gray AL; Gengiah T; Gengiah S; Naidoo A; Jithoo N; Nair G; El-Sadr WM; Friedland G; Abdool Karim Q
N Engl J Med; 2011 Oct; 365(16):1492-501. PubMed ID: 22010915
[TBL] [Abstract][Full Text] [Related]
12. Antiretroviral therapy initiation during tuberculosis treatment and HIV-RNA and CD4 T-lymphocyte responses.
Takuva S; Westreich D; Menezes CN; McNamara L; Sanne I; Page-Shipp L; Maskew M
Int J Tuberc Lung Dis; 2012 Oct; 16(10):1358-64. PubMed ID: 22863288
[TBL] [Abstract][Full Text] [Related]
13. Tuberculosis during the first year of antiretroviral therapy in a South African cohort using an intensive pretreatment screening strategy.
Lawn SD; Kranzer K; Edwards DJ; McNally M; Bekker LG; Wood R
AIDS; 2010 Jun; 24(9):1323-8. PubMed ID: 20386425
[TBL] [Abstract][Full Text] [Related]
14. Timing of antiretroviral therapy for HIV-1 infection and tuberculosis.
Havlir DV; Kendall MA; Ive P; Kumwenda J; Swindells S; Qasba SS; Luetkemeyer AF; Hogg E; Rooney JF; Wu X; Hosseinipour MC; Lalloo U; Veloso VG; Some FF; Kumarasamy N; Padayatchi N; Santos BR; Reid S; Hakim J; Mohapi L; Mugyenyi P; Sanchez J; Lama JR; Pape JW; Sanchez A; Asmelash A; Moko E; Sawe F; Andersen J; Sanne I;
N Engl J Med; 2011 Oct; 365(16):1482-91. PubMed ID: 22010914
[TBL] [Abstract][Full Text] [Related]
15. Time to ART Initiation among Patients Treated for Rifampicin-Resistant Tuberculosis in Khayelitsha, South Africa: Impact on Mortality and Treatment Success.
Daniels JF; Khogali M; Mohr E; Cox V; Moyo S; Edginton M; Hinderaker SG; Meintjes G; Hughes J; De Azevedo V; van Cutsem G; Cox HS
PLoS One; 2015; 10(11):e0142873. PubMed ID: 26555134
[TBL] [Abstract][Full Text] [Related]
16. Timing of antiretroviral therapy in Cambodian hospital after diagnosis of tuberculosis: impact of revised WHO guidelines.
Choun K; Pe R; Thai S; Lorent N; Lynen L; van Griensven J
Bull World Health Organ; 2013 Mar; 91(3):195-206. PubMed ID: 23476092
[TBL] [Abstract][Full Text] [Related]
17. Antiretroviral treatment uptake in patients with HIV-associated TB attending co-located TB and ART services.
Nglazi MD; Kaplan R; Caldwell J; Peton N; Lawn SD; Wood R; Bekker LG
S Afr Med J; 2012 Oct; 102(12):936-9. PubMed ID: 23498041
[TBL] [Abstract][Full Text] [Related]
18. Incidence of Tuberculosis Among HIV-Positive Individuals Initiating Antiretroviral Treatment at Higher CD4 Counts in the HPTN 071 (PopART) Trial in South Africa.
Bock P; Jennings K; Vermaak R; Cox H; Meintjes G; Fatti G; Kruger J; De Azevedo V; Maschilla L; Louis F; Gunst C; Grobbelaar N; Dunbar R; Limbada M; Floyd S; Grimwood A; Ayles H; Hayes R; Fidler S; Beyers N
J Acquir Immune Defic Syndr; 2018 Jan; 77(1):93-101. PubMed ID: 29016524
[TBL] [Abstract][Full Text] [Related]
19. Cost-Effectiveness of Initiating Antiretroviral Therapy at Different Points in TB Treatment in HIV-TB Coinfected Ambulatory Patients in South Africa.
Naidoo K; Grobler AC; Deghaye N; Reddy T; Gengiah S; Gray A; Abdool Karim S
J Acquir Immune Defic Syndr; 2015 Aug; 69(5):576-84. PubMed ID: 26167618
[TBL] [Abstract][Full Text] [Related]
20. The impact of HIV status and antiretroviral treatment on TB treatment outcomes of new tuberculosis patients attending co-located TB and ART services in South Africa: a retrospective cohort study.
Nglazi MD; Bekker LG; Wood R; Kaplan R
BMC Infect Dis; 2015 Nov; 15():536. PubMed ID: 26584607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
